Footnotes

Grant Support: This study was supported by the Broccoli Foundation, the Christopher and Dana Reeve Foundation, Mayo Clinic Center for Clinical and Translational Sciences, Mayo Clinic Rehabilitation Medicine Research Center, Mayo Clinic Transform The Practice, the Craig H. Neilsen Foundation, the Bel13ve in Miracles Foundation, and The Grainger Foundation.

Potential Competing Interests: Drs Gad, Gerasimenko, and Edgerton are shareholders in NeuroRecovery Technologies; Dr Edgerton is president and chair of the company’s board of directors; and Drs Gad, Gerasimenko, and Edgerton hold investorship rights on intellectual property licensed by the regents of the University of California to NeuroRecovery Technologies and its subsidiaries.